跳至主要内容
临床试验/ACTRN12618001498280
ACTRN12618001498280已完成未知

Stabilisation with Nasal High Flow for Intubation of Neonates: The SHINE Trial.

ewborn Research Centre, The Royal Women's Hospital, Melbourne0 个研究点目标入组 251 人开始时间: 2018年9月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
251

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
Days 至 o limit(—)
性别
All

入选标准

  • 1.Any neonate undergoing endotracheal intubation in the delivery room or NICU AND
  • 2.HR greater than or equal to 120bpm at the time of randomisation

排除标准

  • 1. Requirement for immediate endotracheal intubation as determined by the treating clinician, without time for randomisation and potential application of nHF, eg. active cardiopulmonary resuscitation
  • 2. Heart rate <120 bpm at the time of randomisation
  • 3. Contraindication to nHF use (eg. congenital nasal anomaly, congenital diaphragmatic hernia, abdominal wall defects)
  • 4. Nasal intubation planned
  • 5. Cyanotic congenital heart disease
  • 6. Infant with proven or suspected COVID-19, or born to a mother with proven or suspected COVID-19.

研究者

发起方
ewborn Research Centre, The Royal Women's Hospital, Melbourne

相似试验